PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Resurrecting niobium for quantum science

Expanding possibilities for superconducting qubits

2024-02-26
(Press-News.org) For years, niobium was considered an underperformer when it came to superconducting qubits. Now scientists supported by Q-NEXT have found a way to engineer a high-performing niobium-based qubit and so take advantage of niobium’s superior qualities.

When it comes to quantum technology, niobium is making a comeback.

For the past 15 years, niobium has been sitting on the bench after experiencing a few mediocre at-bats as a core qubit material.

Qubits are the fundamental components of quantum devices. One qubit type relies on superconductivity to process information.

Touted for its superior qualities as a superconductor, niobium was always a promising candidate for quantum technologies. But scientists found niobium difficult to engineer as a core qubit component, and so it was relegated to the second string on Team Superconducting Qubit.

Now, a group led by Stanford University’s David Schuster has demonstrated a way to create niobium-based qubits that rival the state-of-the-art for their class.

“This was a promising first foray, having resurrected niobium junctions. … With niobium-based qubits’ broad operational reach, we open up a whole new set of capabilities for future quantum technologies.” — David Schuster, Stanford University

“We’ve shown that niobium is relevant again, expanding the possibilities of what we can do with qubits,” said Alexander Anferov of the University of Chicago’s Physical Science division, one of the lead scientists of the result.

The team’s work is published in Physical Review Applied and was supported in part by Q-NEXT, a U.S. Department of Energy (DOE) National Quantum Information Science Research Center led by DOE’s Argonne National Laboratory.

By harnessing niobium’s standout features, scientists will be able to expand the capabilities of quantum computers, networks and sensors. These quantum technologies draw on quantum physics to process information in ways that outclass their traditional counterparts and are expected to improve areas as varied as medicine, finance and communication.

The niobium advantage

When it comes to superconducting qubits, aluminum has ruled the roost. Aluminum-based superconducting qubits can store information for a relatively long time before the data inevitably disintegrates. These longer coherence times mean more time for processing information.

The longest coherence times for an aluminum-based superconducting qubit are a few hundred millionths of a second. By contrast, in recent years, the best niobium-based qubits yielded coherence times that are 100 times shorter — a few hundred billionths of a second.

Despite that short qubit lifetime, niobium held attractions. A niobium-based qubit can operate at higher temperatures than its aluminum counterpart and so would require less cooling. It can also operate across an eight-times-greater frequency range and a massive 18,000-times-wider magnetic field range compared to aluminum-based qubits, expanding the menu of uses for the superconducting-qubit family.

In one respect, there was no contest between the two materials: Niobium’s operating range trounced aluminum’s. But for years, the short coherence time made the niobium-based qubit a nonstarter.

“No one really made that many qubits out of niobium junctions because they were limited by their coherence,” Anferov said. ​“But our group wanted to make a qubit that could work at higher temperatures and a greater frequncy range — at 1 K and 100 gigahertz. And for both of those properties, aluminum is not sufficient. We needed something else.”

So, the team had another look at niobium.

Losing the lossiness

Specifically, they had a look at the niobium Josephson junction. The Josephson junction is the information-processing heart of the superconducting qubit.

In classical information processing, data comes in bits that are either 0s or 1s. In quantum information processing, a qubit is a mixture of 0 and 1. The superconducting qubit’s information ​“lives” as a mixture of 0 and 1 inside the junction. The longer the junction can sustain the information in that mixed state, the better the junction and the better the qubit.

The Josephson junction is structured like a sandwich, consisting of a layer of nonconducting material squeezed between two layers of superconducting metal. A conductor is a material that provides easy passage for electrical current. A superconductor kicks it up a notch: It carries electrical current with zero resistance. Electromagnetic energy flows between the junction’s outer layers in the mixed quantum state. 

The typical, trusty aluminum Josephson junction is made of two layers of aluminum and a middle layer of aluminum oxide. A typical niobium junction is made of two layers of niobium and a middle layer of niobium oxide.

Schuster’s group found that the junction’s niobium oxide layer sapped the energy required to sustain quantum states. They also identified the niobium junctions’ supporting architecture as a big source of energy loss, causing the qubit’s quantum state to fizzle out.

The team’s breakthrough involved both a new junction arrangement and a new fabrication technique.

The new arrangement called on a familiar friend: aluminum. The design did away with the energy-sucking niobium oxide. And instead of two distinct materials, it used three. The result was a low-loss, trilayer junction — niobium, aluminum, aluminum oxide, aluminum, niobium.

“We did this best-of-both-worlds approach,” Anferov said. ​“The thin layer of aluminum can inherit the superconducting properties of the niobium nearby. This way, we can use the proven chemical properties of aluminum and still have the superconducting properties of niobium.”

The group’s fabrication technique involved removing scaffolding that supported the niobium junction in previous schemes. They found a way to maintain the junction’s structure while getting rid of the loss-inducing, extraneous material that hampered coherence in previous designs.

“It turns out just getting rid of the garbage helped,” Anferov said.

A new qubit is born

After incorporating their new junction into superconducting qubits, the Schuster group achieved a coherence time of 62 millionths of a second, 150 times longer than its best-performing niobium predecessors. The qubits also exhibited a quality factor — an index of how well a qubit stores energy — of 2.57 x 105, a 100-fold improvement over previous niobium-based qubits and competitive with aluminum-based qubit quality factors.

“We’ve made this junction that still has the nice properties of niobium, and we’ve improved the loss properties of the junction,” Anferov said. ​“We can directly outperform any aluminum qubit because aluminum is an inferior material in many ways. I now have a qubit that doesn’t die at higher temperatures, which is the big kicker.”

The results will likely elevate niobium’s place in the lineup of superconducting qubit materials.

“This was a promising first foray, having resurrected niobium junctions,” Schuster said. ​“With niobium-based qubits’ broad operational reach, we open up a whole new set of capabilities for future quantum technologies.”

This work was supported by the DOE Office of Science National Quantum Information Science Research Centers as part of the Q-NEXT center. It was partially supported by the University of Chicago Materials Research Science and Engineering Center, which is funded by the National Science Foundation.

This research was conducted by researchers at DOE’s Argonne National Laboratory, DOE’s Fermi National Accelerator Laboratory, the DOE’s SLAC National Accelerator Laboratory, Stanford University and the University of Chicago.

About Q-NEXT

Q-NEXT is a U.S. Department of Energy National Quantum Information Science Research Center led by Argonne National Laboratory. Q-NEXT brings together world-class researchers from national laboratories, universities and U.S. technology companies with the goal of developing the science and technology to control and distribute quantum information. Q-NEXT collaborators and institutions have established two national foundries for quantum materials and devices, develop networks of sensors and secure communications systems, establish simulation and network test beds, and train the next-generation quantum-ready workforce to ensure continued U.S. scientific and economic leadership in this rapidly advancing field. For more information, visit https://​q​-next​.org/.

Argonne National Laboratory seeks solutions to pressing national problems in science and technology. The nation’s first national laboratory, Argonne conducts leading-edge basic and applied scientific research in virtually every scientific discipline. Argonne researchers work closely with researchers from hundreds of companies, universities, and federal, state and municipal agencies to help them solve their specific problems, advance America’s scientific leadership and prepare the nation for a better future. With employees from more than 60 nations, Argonne is managed by UChicago Argonne, LLC for the U.S. Department of Energy’s Office of Science.

The U.S. Department of Energy’s Office of Science is the single largest supporter of basic research in the physical sciences in the United States and is working to address some of the most pressing challenges of our time. For more information, visit https://​ener​gy​.gov/​s​c​ience.

END


ELSE PRESS RELEASES FROM THIS DATE:

Long-term data reveals SARS-CoV-2 infection and vaccine-induced antibody responses are long-lasting

Long-term data reveals SARS-CoV-2 infection and vaccine-induced antibody responses are long-lasting
2024-02-26
A long-term analysis conducted by leading microbiologists at the Icahn School of Medicine at Mount Sinai reveals that antibody responses induced by COVID-19 vaccines are long-lasting. The study results, published online in the journal Immunity on February 22, challenge the idea that mRNA-based vaccine immunity wanes quickly. The emergence of SARS-CoV-2, the virus that causes COVID-19, in late 2019 sparked the global pandemic that is now in its fifth year. Vaccines that were developed at record speed have saved millions of lives. However, the emergence of SARS-CoV-2 variants and waning immunity have decreased ...

Shaping the future of phage therapy: The 7th World Conference on Targeting Phage Therapy in Malta aims to transform clinical trials through translational research

Shaping the future of phage therapy: The 7th World Conference on Targeting Phage Therapy in Malta aims to transform clinical trials through translational research
2024-02-26
The 7th World Conference on Targeting Phage Therapy 2024, two-day event dedicated to advancing the field of phage research and therapy will be hosted at Corinthia Palace Malta on June 20-21. Robert T. Schooley, M.D., Professor of Medicine at the University of California, San Diego, Co-Director of the Center for Innovative Phage Applications and Therapeutics, and member of the Executive Committee for the University of California Disaster Resilience Network, will introduce the messages and strategies behind phages therapy 2024. His talk titled “Phage Therapeutics 2024: Essential Translational Research Components for ...

GZ17-6.02 with bexarotene kills mycosis fungoides cells

GZ17-6.02 with bexarotene kills mycosis fungoides cells
2024-02-26
“The present studies were performed to extend our knowledge of GZ17-6.02 biology from that known in solid tumor cell types such as prostate cancer cells to liquid tumor cell types, for example, mycosis fungoides.” BUFFALO, NY- February 26, 2024 – A new research paper was published in Oncotarget's Volume 15 on February 8, 2024, entitled, “GZ17-6.02 interacts with bexarotene to kill mycosis fungoides cells.” In this new study, researchers Michael R. Booth, Laurence Booth, Jane L. Roberts, Cameron West, and Paul Dent from Virginia Commonwealth University and Genzada Pharmaceuticals investigated the therapeutic agent GZ17-6.02, composed of curcumin, ...

University of Tennessee Health Science Center professor awarded $1.5m to study 'root causes' of disparity in breast cancer survival of Black women and white women

University of Tennessee Health Science Center professor awarded $1.5m to study root causes of disparity in breast cancer survival of Black women and white women
2024-02-26
Memphis, Tenn. (February 26, 2024) – Shelley White-Means, PhD, a professor of Health Economics in the Department of Interprofessional Education and the director of the Consortium for Health Education, Economic Empowerment and Research (CHEER) at UT Health Science Center, recently received a $1.5 million, four-year grant from the National Institute on Minority Health and Health Disparities to explore the root causes of the disparity in breast cancer survival of Black women compared to white women.   Dr. White-Means and a team will look beyond the social determinants of health to explore what she terms “the intersectionality of race, ...

Steering and accelerating electrons at the microchip scale

2024-02-26
Stanford researchers are getting closer to building a tiny electron accelerator based on “accelerator-on-a-chip” technology with broad potential applications in studying physics as well as medical and industrial uses. The researchers have demonstrated that a silicon dielectric laser accelerator, or DLA, can now both speed up and confine electrons, creating a focused beam of high-energy electrons. “If the electrons were microscopic cars, it’s as if, for the first time, we’re steering and we have our foot on the gas,” said Payton Broaddus, PhD ’23 in electrical engineering and the lead author on a paper published on ...

City of Hope scientists devise novel strategy to seek and destroy leukemia stem cells

City of Hope scientists devise novel strategy to seek and destroy leukemia stem cells
2024-02-26
FINDINGS Scientists at City of Hope, one of the largest cancer research and treatment organizations in the United States, have devised an innovative approach to target and destroy hard-to-kill leukemia stem cells. The journal Blood published the preclinical findings today. By overcoming challenges, such as drug resistance and treatment relapse common to patients with acute myeloid leukemia (AML), the therapy method could provide a less toxic and more effective approach for older and sicker patients who don’t quality for stem cell transplants — currently the only cure for AML available. Type II interferon (IFNy), a substance produced by immune cells, disrupts ...

Laser-focused look at spinning electrons shatters world record for precision

Laser-focused look at spinning electrons shatters world record for precision
2024-02-26
NEWPORT NEWS, VA – Scientists are getting a more detailed look than ever before at the electrons they use in precision experiments. Nuclear physicists with the U.S. Department of Energy’s Thomas Jefferson National Accelerator Facility have shattered a nearly 30-year-old record for the measurement of parallel spin within an electron beam – or electron beam polarimetry, for short. The achievement sets the stage for high-profile experiments at Jefferson Lab that could open the door to new physics discoveries. In a peer-reviewed ...

BU researchers identify potential new subtype of chronic traumatic encephalopathy

2024-02-26
FOR IMMEDIATE RELEASE, February 26, 2024 Contact: Gina DiGravio, 617-358-7838, ginad@bu.edu BU Researchers Identify Potential New Subtype of Chronic Traumatic Encephalopathy One in six cases have a distinct distribution of disease, clinical profile (Boston)—Chronic traumatic encephalopathy (CTE) is a neurodegenerative disease defined by abnormal tau protein accumulating in a particular pattern in specific regions of the brain.   Studies to-date suggest CTE begins in the outermost layer of the frontal lobe, the neocortex, where it then spreads to connected brain regions. Later, in high-stage disease, ...

BU researchers describe new technological platform to accelerate drug development

2024-02-26
EMBARGOED by Cell until 11 am ET Feb. 26, 2024 Contact: Gina DiGravio, 617-358-7838, ginad@bu.edu   BU Researchers Describe New Technological Platform to   Accelerate Drug Development   (Boston)— Drug development is currently an extremely long, expensive and inefficient process. Findings generated in a lab are often very hard to replicate once translated into animal models or in humans.   A family of pharmacological targets, on which approximately 35% of FDA-approved drugs work, consists of receptors at the surface ...

The small intestine adapt its size according to nutrient intake

2024-02-26
One of the most striking examples of gut plasticity can be observed in animals that are exposed to prolonged periods of fasting, such as hibernating animals or phyton snakes that goes for months without eating, where the gut shrinks with as much as 50%, but recovers in size following a few days of re-feeding. Importantly, the capacity of the gut to undergo resizing is broadly conserved. Hence, in humans, an increase in gut size is observed during pregnancy, which facilitates the uptake of nutrients to support the growth of the fetus. The Colombani Andersen ...

LAST 30 PRESS RELEASES:

UK study shows there is less stigma against LGBTQ people than you might think, but people with mental health problems continue to experience higher levels of stigma

Bringing lost proteins back home

Better than blood tests? Nanoparticle potential found for assessing kidneys

Texas A&M and partner USAging awarded 2024 Immunization Neighborhood Champion Award

UTEP establishes collaboration with DoD, NSA to help enhance U.S. semiconductor workforce

Study finds family members are most common perpetrators of infant and child homicides in the U.S.

Researchers secure funds to create a digital mental health tool for Spanish-speaking Latino families

UAB startup Endomimetics receives $2.8 million Small Business Innovation Research grant

Scientists turn to human skeletons to explore origins of horseback riding

UCF receives prestigious Keck Foundation Award to advance spintronics technology

Cleveland Clinic study shows bariatric surgery outperforms GLP-1 diabetes drugs for kidney protection

Study reveals large ocean heat storage efficiency during the last deglaciation

Fever drives enhanced activity, mitochondrial damage in immune cells

A two-dose schedule could make HIV vaccines more effective

Wastewater monitoring can detect foodborne illness, researchers find

Kowalski, Salonvaara receive ASHRAE Distinguished Service Awards

SkAI launched to further explore universe

SLU researchers identify sex-based differences in immune responses against tumors

Evolved in the lab, found in nature: uncovering hidden pH sensing abilities

Unlocking the potential of patient-derived organoids for personalized sarcoma treatment

New drug molecule could lead to new treatments for Parkinson’s disease in younger patients

Deforestation in the Amazon is driven more by domestic demand than by the export market

Demand-side actions could help construction sector deliver on net-zero targets

Research team discovers molecular mechanism for a bacterial infection

What role does a tailwind play in cycling’s ‘Everesting’?

Projections of extreme temperature–related deaths in the US

Wearable device–based intervention for promoting patient physical activity after lung cancer surgery

Self-compassion is related to better mental health among Syrian refugees

Microplastics found in coral skeletons

Stroke rates increasing in individuals living with SCD despite treatment guidelines

[Press-News.org] Resurrecting niobium for quantum science
Expanding possibilities for superconducting qubits